4.6 Article

Vasoactive intestinal peptide induces IL-8 production in human colonic epithelial cells via MAP kinase-dependent PKA-independent pathways

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2004.03.033

Keywords

vasoactive intestinal peptide; neuropeptide; chemokine IL-8; MAP kinase; human colonic epithelial cells

Ask authors/readers for more resources

Vasoactive intestinal peptide (VIP) has been shown to be a key regulator of intestinal epithelial functions Such as MUCUS and chloride secretion, paracellular permeability, and cell proliferation. However, its regulatory role in intestinal epithelial chemokine Production remains unknown. The aim of this Study was ( I) to determine whether VIP can modulate intestinal epithelial interleukin-8 (IL-8) production and (2) to identify intracellular mediators responsible for this effect. In the human colonic epithelial cell line HT29-Cl. 16E, VIP stimulates IL-8 secretion dose-dependently and IL-8 mRNA level at 10(-9) M. The protein kinase A (PKA) inhibitor PKI did not abolish the effect of VIP. However, inhibition of the ERK1/2 and p38 MAPK pathways reduced the VIP-stimulated IL-8 secretion and mRNA level. Together, our results showed that VIP stimulates IL-8 production in intestinal epithelial cells via PKA-independent and MAPK-dependent pathways. These data suggest that VIPergic pathways can play an immuno-modulatory role in intestinal epithelial cells, by regulating epithelial IL-8 secretion. (C) 2004 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available